Bend Research has announced the addition of a new stand-alone cGMP spray-drying facility for high potency drug development and manufacturing, including inhalation biotherapeutics. The company offers a range of development and particle engineering services for OINDPs.
Bend Research CEO Rod Ray said, “We’re excited to offer our clients expanded cGMP spray-drying capability for high-potency compounds. This facility will complement our small molecule cGMP spray drying capabilities.”
The new building is separated from the other facilities on the Bend campus and is maintained to ISO Class 8 clean room classification standards. It is part of a recent expansion program that includes several other facilities.
Read the Bend Research press release.
